Nictiz FHIR NL STU3 Zib2017
1.3.15 - CI Build
Nictiz FHIR NL STU3 Zib2017 - Local Development build (v1.3.15) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2025-09-22 |
Mappings for the zib-SkinDisorder resource profile.
No Mappings Found
No Mappings Found
Name | HCIM SkinDisorder-v3.2(2017EN) | SNOMED CT Concept Domain Binding | W5 Mapping![]() |
---|---|---|---|
![]() ![]() |
19.3.1 SkinDisorder |
246090004 |Associated finding| =
((< 404684003 |Clinical finding| MINUS
<< 420134006 |Propensity to adverse reactions| MINUS
<< 473010000 |Hypersensitivity condition| MINUS
<< 79899007 |Drug interaction| MINUS
<< 69449002 |Drug action| MINUS
<< 441742003 |Evaluation finding| MINUS
<< 307824009 |Administrative status| MINUS
<< 385356007 |Tumor stage finding|) OR
< 272379006 |Event|) |
clinical.general |
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
19.3.7 Cause |
||
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
id | ||
![]() ![]() ![]() |
< 303105007 |Disease phases| |
status | |
![]() ![]() ![]() |
< 410514004 |Finding context value| |
status | |
![]() ![]() ![]() |
< 404684003 |Clinical finding| |
class | |
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() |
< 272141005 |Severities| |
grade | |
![]() ![]() ![]() |
19.3.2 TypeOfDisorder |
code 246090004 |Associated finding| (< 404684003 |Clinical finding| MINUS
<< 420134006 |Propensity to adverse reactions| MINUS
<< 473010000 |Hypersensitivity condition| MINUS
<< 79899007 |Drug interaction| MINUS
<< 69449002 |Drug action| MINUS
<< 441742003 |Evaluation finding| MINUS
<< 307824009 |Administrative status| MINUS
<< 385356007 |Tumor stage finding|)
OR < 413350009 |Finding with explicit context|
OR < 272379006 |Event| |
what |
![]() ![]() ![]() |
19.3.4 AnatomicalLocation |
< 442083009 |Anatomical or acquired body structure| |
|
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
19.3.8 Laterality |
||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() |
who.focus | ||
![]() ![]() ![]() |
context | ||
![]() ![]() ![]() |
when.init | ||
![]() ![]() ![]() ![]() |
19.3.3 DateOfOnset |
when.init | |
![]() ![]() ![]() |
when.done | ||
![]() ![]() ![]() |
when.recorded | ||
![]() ![]() ![]() |
who.author | ||
![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
< 254291000 |Staging and scales| |
||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
|||
![]() ![]() ![]() ![]() |
< 404684003 |Clinical finding| |
why | |
![]() ![]() ![]() ![]() |
why | ||
![]() ![]() ![]() |
19.3.6 Comment |
||
![]() |